Tenderwize
Wróć do wyszukiwania

Open-house rebate agreements for colchicine

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Aug 03, 2027 · 340 days left·Open·Supplies·Framework
Zarejestruj się, aby zapisaćOpen documents
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Colchicin, ATC M04AC01

56/100

Ocena szansy

Needs reviewMedium complexity
SuppliesFrameworkOpen
Skąd ta ocena?

Szansa

56 / 100

Złożoność

48 / 100

Czynniki ryzyka

Submitting the contract documents in the wrong DTVP area is explicitly prohibited; they must be sent via the communicat...

To obtain the next monthly start date, complete documents must be received by the 3rd of the month; for paper filings...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Sep 2027
  • Non-exclusive rebate agreements for pharmaceutical products containing colchicine (ATC M04AC01).
  • Open-house model with identical, non-individually negotiable contract terms for all eligible pharmaceutical companies.
Pokaż pełne podsumowanie

Open-house supply arrangement for pharmaceutical products: AOK Bayern seeks non-exclusive rebate agreements for colchicine (ATC M04AC01) with all interested pharmaceutical companies that meet the stated suitability requirement. This is explicitly described as an open-house model, not a competitive open procedure, with no selection among bidders and no negotiated contract terms. The contract period runs from 2025-10-01 to 2027-09-30, and applications can be submitted until 2027-08-03 12:00 local time; for monthly start dates, complete documents must arrive by the 3rd of the month, with paper originals by the 10th if scanned in advance.

Ryzyka

Submitting the contract documents in the wrong DTVP area is explicitly prohibited; they must be sent via the communicat...

To obtain the next monthly start date, complete documents must be received by the 3rd of the month; for paper filings...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • A signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit) must be submitted.
  • The contract must be submitted completed and signed; signatory authority must be evidenced by the commercial register extract or a power of attorney.

Zamawiający

Lokalizacja

München, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE811695320

Działalność

Health

Części (1)

LOT-0001

Open-house rebate agreements for colchicine

Supply of pharmaceutical products under an open-house rebate agreement for the active substance colchicine (ATC M04AC01). The lot is for non-exclusive, identical contract terms for interested pharmaceutical companies. Place of performance is Germany, Bavaria (DE212).

SuppliesFrameworkEU fundedElectronic submission

Lokalizacja

DE212, Germany

Czas trwania

Sep 2025 - Sep 2027

Kategoria

Pharmaceutical products

Termin

Deadline Aug 03, 2027

Szczegóły zamówienia

Data publikacji
13 Aug 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
532530-2025

Dokumenty (2)

Dokument zamówienia 1Portal składania ofert 1

Podobne przetargi

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30